Ono Pharmaceutical Total Assets 2006-2018 | OPHLF

Ono Pharmaceutical total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Ono Pharmaceutical total assets for the quarter ending June 30, 2018 were $5.692B, a INF% increase year-over-year.
  • Ono Pharmaceutical total assets for 2018 were $5.747B, a 4.25% increase from 2017.
  • Ono Pharmaceutical total assets for 2017 were $5.513B, a 14.25% increase from 2016.
  • Ono Pharmaceutical total assets for 2016 were $4.825B, a 10.38% increase from 2015.
Ono Pharmaceutical Annual Total Assets
(Millions of US $)
2018 $5,747
2017 $5,513
2016 $4,825
2015 $4,372
2014 $4,764
2013 $4,847
2012 $5,322
2011 $0
2010 $0
2009 $0
2008 $0
2007 $0
2006 $0
2005 $0
Ono Pharmaceutical Quarterly Total Assets
(Millions of US $)
Q1 2018 $5,692
Q1 2017 $5,155
Q1 2016 $5,298
Q4 2016 $4,825
Q3 2015 $0
Q2 2015 $4,341
Q1 2015 $4,326
Q4 2015 $4,372
Q3 2014 $4,214
Q2 2014 $4,473
Q1 2014 $4,844
Q4 2014 $4,764
Q3 2013 $4,512
Q2 2013 $4,702
Q1 2013 $4,592
Q4 2013 $4,847
Q3 2012 $4,985
Q2 2012 $5,513
Q1 2012 $5,402
Q4 2012 $5,322
Q3 2011 $5,477
Q1 2011 $0
Q4 2011 $0
Q1 2010 $0
Q1 2009 $0
Q1 2008 $0
Q1 2007 $0
Q1 2006 $0
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $9.212B $2.604B
Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.649B 36.12
Takeda Pharmaceutical (TAK) Japan $54.706B 8.56
Astellas Pharma (ALPMY) Japan $31.284B 14.91
Eisai (ESALY) Japan $19.483B 29.83
Merck (MKGAF) Germany $15.238B 20.79
UCB SA (UCBJF) Belgium $14.373B 0.00
Grifols, S.A (GRFS) Spain $14.294B 18.24
Neurocrine Biosciences (NBIX) United States $8.986B 0.00
IPSEN SA ADR (IPSEY) France $8.872B 0.00
Ionis Pharmaceuticals (IONS) United States $7.690B 16.58
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Sage Therapeutics (SAGE) United States $7.216B 0.00
Catalent (CTLT) United States $7.080B 27.98
Jazz Pharmaceuticals (JAZZ) Ireland $6.939B 9.13
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.094B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Hypermarcas (HYPMY) Brazil $5.292B 19.02
Orion OYJ (ORINY) Finland $5.271B 27.14
Arrowhead Pharmaceuticals (ARWR) United States $3.695B 84.73
United Therapeutics (UTHR) United States $3.695B 0.00
FibroGen (FGEN) United States $3.443B 86.11
Evotec AG (EVTCY) Germany $3.224B 44.14
Nektar Therapeutics (NKTR) United States $3.015B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.993B 10.73
PTC Therapeutics (PTCT) United States $2.304B 0.00
Tilray (TLRY) Canada $2.163B 0.00
Xencor (XNCR) United States $2.060B 44.93
Portola Pharmaceuticals (PTLA) United States $1.936B 0.00
Zogenix (ZGNX) United States $1.924B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.644B 59.82
USANA Health Sciences (USNA) United States $1.616B 16.77
Corcept Therapeutics (CORT) United States $1.591B 21.86
Heron Therapeutics (HRTX) United States $1.483B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.410B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.251B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.195B 19.72
ArQule (ARQL) United States $1.148B 0.00
Endo (ENDP) Ireland $1.064B 1.87
Aerie Pharmaceuticals (AERI) United States $0.965B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.945B 0.00
TherapeuticsMD (TXMD) United States $0.907B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.900B 4.01
Spectrum Pharmaceuticals (SPPI) United States $0.893B 0.00
Dova Pharmaceuticals (DOVA) United States $0.810B 0.00
Organogenesis Holdings (ORGO) United States $0.716B 0.00
Karyopharm Therapeutics (KPTI) United States $0.704B 0.00
Concordia (CXRXF) Canada $0.588B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.565B 0.00
Flexion Therapeutics (FLXN) United States $0.562B 0.00
Akebia Therapeutics (AKBA) United States $0.506B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.472B 0.00
Lannett Co Inc (LCI) United States $0.472B 4.97
Aptorum Group (APM) Hong Kong, SAR China $0.464B 0.00
ChemoCentryx (CCXI) United States $0.460B 0.00
Translate Bio (TBIO) United States $0.449B 0.00
Siga Technologies (SIGA) United States $0.441B 1.03
Indivior (INVVY) United States $0.440B 1.59
ImmunoGen (IMGN) United States $0.418B 0.00
Dermira (DERM) United States $0.400B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.396B 0.00
Collegium Pharmaceutical (COLL) United States $0.382B 0.00
DURECT (DRRX) United States $0.380B 0.00
Innate Pharma SA (IPHYF) France $0.363B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.346B 15.74
Corbus Pharmaceuticals Holdings (CRBP) United States $0.334B 0.00
OptiNose (OPTN) United States $0.327B 0.00
Molecular Templates (MTEM) United States $0.327B 0.00
Harpoon Therapeutics (HARP) United States $0.318B 0.00
Ardelyx (ARDX) United States $0.315B 0.00
Rafael Holdings (RFL) United States $0.305B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.283B 0.00
Recro Pharma (REPH) United States $0.282B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.263B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.229B 0.00
GlycoMimetics (GLYC) United States $0.222B 0.00
Xeris Pharmaceuticals (XERS) United States $0.214B 0.00
CV Sciences (CVSI) United States $0.198B 0.00
KalVista Pharmaceuticals (KALV) United States $0.197B 0.00
CannTrust Holdings (CTST) Canada $0.188B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.186B 0.00
Nature's Sunshine Products (NATR) United States $0.180B 30.03
Foamix Pharmaceuticals (FOMX) Israel $0.179B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.174B 0.00
Ocular Therapeutix (OCUL) United States $0.171B 0.00
Taiwan Liposome (TLC) Taiwan $0.168B 0.00
IMV INC (IMV) Canada $0.148B 0.00
Calithera Biosciences (CALA) United States $0.146B 0.00
Concert Pharmaceuticals (CNCE) United States $0.146B 0.00
Redhill Biopharma (RDHL) Israel $0.145B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.136B 0.00
MEI Pharma (MEIP) United States $0.124B 0.00
Generex Biotechnology (GNBT) United States $0.123B 0.00
Jounce Therapeutics (JNCE) United States $0.116B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.76
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Aquestive Therapeutics (AQST) United States $0.080B 0.00
MediWound (MDWD) Israel $0.077B 0.00
Majesco Entertainment (PTE) United States $0.077B 0.00
Lipocine (LPCN) United States $0.076B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.070B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Melinta Therapeutics (MLNT) United States $0.067B 0.00
Aclaris Therapeutics (ACRS) United States $0.067B 0.00
Natural Alternatives (NAII) United States $0.065B 9.78
AgeX Therapeutics (AGE) United States $0.064B 0.00
Infinity Pharmaceuticals (INFI) United States $0.063B 0.00
Novan (NOVN) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
IntelGenx Technologies (IGXT) Canada $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.053B 0.00
Nivalis Therapeutics (ALPN) United States $0.052B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
Capnia (SLNO) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
CTI BioPharma (CTIC) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
India Globalization Capital (IGC) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Mast Therapeutics (SVRA) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Biomerica (BMRA) United States $0.031B 0.00
PharmAthene (ALT) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Shineco (TYHT) China $0.015B 18.08
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.013B 0.00
Vical (BBI) United States $0.012B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00